The global COVID-19 diagnostics market, which reached a valuation of USD 30.02 billion in 2024, is experiencing a significant contraction phase as the pandemic transitions to an endemic state. Market projections indicate a decline from USD 26.08 billion in 2025 to approximately USD 7.26 billion by 2034, representing a compound annual growth rate of -13.3% during the forecast period. This...